Press Releases

Press Releases

Filters
Viatris Inc. to Participate in BofA Global Research Global Healthcare Conference
Viatris Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
Viatris to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Viatris Publishes Sustainability Report Highlighting 2021 Progress, Achievements and Goals
Viatris’ Dividend Reinvestment and Share Purchase Plan
Viatris Inc. to Release First Quarter 2022 Financial Results on May 9, 2022
Sesame Workshop and Viatris Launch New Emotional Health and Wellbeing Resources for Families Grappling with Effects of COVID-19
Viatris Defeats Biogen's Attempt to Revive Tecfidera Patent
Viatris Inc. Announces Receipt of the First FDA Approval for Generic Version of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in Partnership with Kindeva
Viatris to Participate in Upcoming Investor Conferences
Displaying 1 - 10 of 47